Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis

ClinicalTrials.gov ID: NCT01926028

Public ClinicalTrials.gov record NCT01926028. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 1b/2a, Multi-center, Double-blind, Randomized, Placebo-controlled Study of a Single Dose of NDV-3A or NDV-3 Vaccine to Evaluate Safety, Tolerability, Immunogenicity and Efficacy in Preventing Recurrent Vulvovaginal Candidiasis

Study identification

NCT ID
NCT01926028
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
NovaDigm Therapeutics, Inc.
Industry
Enrollment
188 participants

Conditions and interventions

Interventions

  • NDV-3A Biological
  • NDV-3 Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2013
Primary completion
Apr 30, 2015
Completion
Apr 30, 2016
Last update posted
Jul 17, 2018

2013 – 2016

United States locations

U.S. sites
20
U.S. states
11
U.S. cities
20
Facility City State ZIP Site status
Precision Trials LLC Phoenix Arizona 85032
Arkansas Women's Center Little Rock Arkansas 72205
Women's Health Care Research Corp San Diego California 92123
McCann MD Research, Inc. Torrance California 90505
Women's Medical Research Group, LLC Clearwater Florida 33759
KO Clinical Research, LLC Fort Lauderdale Florida 33316
Miami Clinical Research, LLC Miami Florida 33155
Community Medical Research Miami Beach Florida 33141
Community Medical Research LLC North Miami Florida 33181
MedPharmics Metairie Louisiana 70006
WSU Physician's Group Detroit Michigan 48201
Saginaw Valley Medical Research Group, LLC Saginaw Michigan 48604
Lawrence OB/Gyn Clinical Research Lawrenceville New Jersey 08648
SUNY Downstate Medical Center Brooklyn New York 11203
Suffolk Ob/Gyn Port Jefferson New York 11777
Drexel University College of Medicine Philadelphia Pennsylvania 19102
Magnolia OB/GYN Research Center, LLC Myrtle Beach South Carolina 29752
Advanced Research Associates Corpus Christi Texas 78414
Discovery Clinical Trials- HCWC, LLC Dallas Texas 75231
TMC Life Research Houston Texas 77054

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01926028, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 17, 2018 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01926028 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →